21 results
8-K
EX-1.1
LPCN
Lipocine Inc
27 Jan 21
Lipocine Prices $25 Million
9:02am
for the plaintiff in any such action, the indemnifying party(s) agree(s) to indemnify and hold harmless any Underwriter and any such controlling
8-K
EX-99.1
LPCN
Lipocine Inc
31 Jul 20
Lipocine Announces Derivative Suit Was Dismissed
8:41am
that the plaintiff had failed to allege demand futility as required under Delaware Chancery Rule 23.1.
About Lipocine
Lipocine Inc. is a clinical-stage
424B5
LPCN
Lipocine Inc
26 Feb 20
Prospectus supplement for primary offering
8:02am
, the Plaintiff filed a motion for preliminary approval of the settlement along with a copy of the parties’ stipulation of settlement. On March 21, 2018
424B5
tizjzr0ynsgzba4
15 Nov 19
Prospectus supplement for primary offering
1:58pm
424B5
pv9d1uvv 6s63vl4bp
14 Nov 19
Prospectus supplement for primary offering
4:06pm
424B5
zvgr4t8c8 lyzyzvm
13 Nov 19
Prospectus supplement for primary offering
4:01pm